chapter
Thrombolytics
Pages 2

Additive effect on clotting cascade Watch for bleeding complications. Risk-benefit analysis is needed before co-administering; this will involve availability of alternative therapies such as primary angioplasty

THROMBOLYTICS

THROMBOLYTICS ANTICOAGULANTS – PARENTERAL

THROMBOLYTICS HEPARINS Heparin requirements are ≠ when administered after streptokinase

Uncertain at present Monitor APTT closely when starting heparin after streptokinase.